Home/Navidea Biopharmaceuticals/John K. Scott, Jr.
JK

John K. Scott, Jr.

Vice Chair of the Board

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals Pipeline

DrugIndicationPhase
Tc99m TilmanoceptLymphatic Mapping (Breast Cancer, Melanoma)Approved
Manocept DiagnosticKaposi's SarcomaPreclinical/Phase 1
Manocept TherapeuticOncology / Inflammatory DiseasesResearch